So not only has market discounted MK's claim without FDA corroboration, but the phrase "offers manufacturers an opportunity.................to efficiently address topics as they arise during the premarket review phase." is key to how useless BDD is at moment when RDGL hasn't even gone to human trials yet. RDGL is nowhere near the "premarket review phase" for Radiogel, and appears years away from that step if they ever get there. Gotta do human trials first.
And where's the promised quarterly update? Wtf is MK doing?
News 
Market Data 
Discover 
AI
